1. Protein Tyrosine Kinase/RTK
  2. PDGFR
  3. GZD856


Cat. No.: HY-101489
Handling Instructions

GZD856 is a novel and orally bioavailable PDGFRα/β inhibitor with IC50s of 68.6 and 136.6 nM, respectively. Anti-lung cancer activities. Also a Bcr-AblT315I inhibitor with IC50s of 19.9 and 15.4 nM for Bcr-Abl and T315I mutant.

For research use only. We do not sell to patients.

GZD856 Chemical Structure

GZD856 Chemical Structure

CAS No. : 1257628-64-0

Size Stock
100 mg Get quote
250 mg Get quote
500 mg Get quote

* Please select Quantity before adding items.

Top Publications Citing Use of Products

View All PDGFR Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review


GZD856 is a novel and orally bioavailable PDGFRα/β inhibitor with IC50s of 68.6 and 136.6 nM, respectively. Anti-lung cancer activities[1]. Also a Bcr-AblT315I inhibitor with IC50s of 19.9 and 15.4 nM for Bcr-Abl and T315I mutant[2].

IC50 & Target[1]


68.6 nM (IC50)


136.6 nM (IC50)


15.4 nM (IC50)


19.9 nM (IC50)

In Vitro

GZD856 (0.0032-10 μM, 72 h) exerts antiproliferative activity against a panel of lung cancer cells[1].

GZD856 shows dose-dependent inhibition of PDGFRα and PDGFRβ phosphorylation in H1703 and A549 cells, respectively. The activation of downstream AKT (phosphorylation of S473 but not T308), ERK1/2 and STAT3 is also observed after exposure to GZD856, with no obvious effects on total protein levels[1].

GZD856 induces dose-dependent G0/G1 phase arrest and apoptosis in H1703 cells but not in A549 cells[1].

GZD856 strongly suppresses the proliferation of K562, K562R (Q252H) and murine Ba/F3 cells ectopically expressing Bcr-AblWT and Bcr-AblT315I, with IC50s of 2.2, 67.0, 0.64 and 10.8 nM, respectively[2].

Cell Viability Assay[1]

Cell Line: H1703, A549, Calu-6, 95-D, L-78,HCC827, SPCA-1, H1650, H1299, H522, H332 and H820 NSCLC cells.
Concentration: 0.0032-10 μM
Incubation Time: 72 h
Result: GZD856 displays an IC50 of 0.25 μM against the PDGFRα-overexpressing H1703 cells but is 4–60-fold less potent against PDGFRαnegative human lung cancer cell lines regardless of PDGFRβ expression levels[1].
In Vivo

GZD856 (10 and 30 mg/kg/day, 16 days) displays good in vivo antitumor activity in both H1703 and A549 lung cancer models[1].

A 25-mg/kg oral dose of GZD856 exhibits a long half-life of 22.2 h, optimal plasma exposure (Cmax, 899.5 μg/L) and a good oral bioavailability of 78%[1].

GZD856 (10 mg/kg/day, 8 days, oral) potently suppresses tumor growth in mouse bearing xenograft K562 and Ba/F3 cells expressing Bcr-AblT315I[2].

Animal Model: Male CB17-SCID mice (H1703 and A549 cancer cells)[1]
Dosage: 10, 30 mg/kg
Administration: Oral gavage,daily,16 consecutive days
Result: GZD856 exhibits dose-dependent antitumor efficacy in the xenografted mouse with H1703 cancer cells, with tumor growth inhibition (TGI) values of 20.8% and 74.1% at dosages of 10 and 30 mg/kg/day, respectively. GZD856 also displays obvious in vivo antitumor effects in A549- xenograft mice, with a TGI value of 51.1% at 30 mg/kg[1].
Molecular Weight









Room temperature in continental US; may vary elsewhere.


Please store the product under the recommended conditions in the Certificate of Analysis.

  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2


GZD856GZD 856GZD-856PDGFRBcr-AblPlatelet-derived growth factor receptorInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product name



Applicant name *


Email address *

Phone number *


Organization name *

Country or Region *


Requested quantity *


Bulk Inquiry

Inquiry Information

Product name:
Cat. No.:
MCE Japan Authorized Agent: